Anticoagulation anticoagulants. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Femoral Vein Iliac Vein Atrial Appendage Mesenteric Veins Vena Cava, Inferior Aortic Valve Plasma Blood Platelets Leg Mitral Valve Subclavian Vein Portal Vein Heart Atria Axillary Vein Popliteal Vein

Organisms4

Sea Cucumbers Seaweed Phaeophyta Ancylostoma

Diseases56

Thromboembolism Hemorrhage Venous Thrombosis Thrombosis Atrial Fibrillation Pulmonary Embolism Venous Thromboembolism Thrombophlebitis Antiphospholipid Syndrome Thrombophilia Blood Coagulation Disorders Stroke Embolism Hematoma Recurrence Cerebral Hemorrhage Intracranial Hemorrhages Activated Protein C Resistance Intracranial Embolism and Thrombosis Postoperative Hemorrhage Antithrombin III Deficiency Protein C Deficiency Thrombocytopenia Postthrombotic Syndrome Heart Valve Diseases Heart Diseases Protein S Deficiency Cerebrovascular Disorders Sinus Thrombosis, Intracranial Coronary Thrombosis Pregnancy Complications, Cardiovascular Disseminated Intravascular Coagulation Pregnancy Complications, Hematologic Postoperative Complications Intracranial Embolism Postphlebitic Syndrome Intracranial Thrombosis Hematoma, Subdural Ischemic Attack, Transient Brain Ischemia Lupus Erythematosus, Systemic Hematoma, Epidural, Spinal Hypoprothrombinemias Acute Disease Endocarditis Hemorrhagic Disorders Carotid Artery, Internal, Dissection Coagulation Protein Disorders Budd-Chiari Syndrome Carotid Artery Thrombosis Sagittal Sinus Thrombosis Mesenteric Vascular Occlusion Myocardial Infarction Embolism, Cholesterol Gastrointestinal Hemorrhage Cerebral Infarction

Chemicals and Drugs86

Anticoagulants Warfarin Heparin Acenocoumarol Lupus Coagulation Inhibitor Phenprocoumon Heparin, Low-Molecular-Weight beta-Alanine Vitamin K Protein C Antithrombins Factor Xa Heparin Antagonists 4-Hydroxycoumarins Phenindione Blood Coagulation Factors Rodenticides Prothrombin Protein S Platelet Aggregation Inhibitors Fibrinolytic Agents Aspirin Enoxaparin Thrombomodulin Hirudins Thrombin Pipecolic Acids Antithrombin III Vitamin K Epoxide Reductases Antibodies, Antiphospholipid Fibrin Fibrinogen Degradation Products Coagulants Benzimidazoles Citric Acid Thiophenes Dalteparin Factor V Heparinoids Protamines Thromboplastin Coumarins Antibodies, Anticardiolipin Factor X Pyridones Citrates Dermatan Sulfate beta 2-Glycoprotein I Dicumarol Ancrod Factor Va Antithrombin Proteins Ticlopidine Nadroparin Factor VII Morpholines Factor VIIa Polysaccharides Heparin Cofactor II Antifibrinolytic Agents Fibrin Cardiolipins Fibrinogen Hemostatics Platelet Factor 4 Heparin Lyase Azetidines Mixed Function Oxygenases Recombinant Proteins Benzylamines Fibrinopeptide A Factor IXa Vitamin K 1 Heparitin Sulfate Blood Coagulation Factor Inhibitors Aryl Hydrocarbon Hydroxylases Arthropod Proteins Factor VIIIa Kaolin Aptamers, Nucleotide Diatomaceous Earth Tissue Plasminogen Activator Factor VIII Phospholipids Pyrazoles Chromogenic Compounds beta-Thromboglobulin

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

International Normalized Ratio Prothrombin Time Partial Thromboplastin Time Whole Blood Coagulation Time Blood Coagulation Tests Administration, Oral Drug Monitoring Thrombin Time Treatment Outcome Heart Valve Prosthesis Vena Cava Filters Risk Factors Hemofiltration Retrospective Studies Prospective Studies Follow-Up Studies Hirudin Therapy Thrombolytic Therapy Electric Countershock Risk Assessment Perioperative Care Echocardiography, Transesophageal Drug Substitution Hemostatic Techniques Phlebography Drug Administration Schedule Drug Therapy, Combination Tomography, X-Ray Computed Incidence Thrombectomy Bioprosthesis Heart Valve Prosthesis Implantation Randomized Controlled Trials as Topic Drug Dosage Calculations Premedication Stents Embolectomy Renal Dialysis Drug Therapy, Computer-Assisted Platelet Count Thrombelastography Cohort Studies Bleeding Time Catheterization, Peripheral Clinical Protocols Clinical Trials as Topic Oral Surgical Procedures Withholding Treatment Ultrasonography, Doppler, Duplex Ambulatory Care Injections, Subcutaneous Hemodiafiltration Blood Preservation Patient Selection Blood Specimen Collection Angioplasty, Balloon, Coronary Perioperative Period Echocardiography Feasibility Studies Chi-Square Distribution Catheter Ablation Infusions, Intravenous Cardiopulmonary Bypass Vascular Surgical Procedures Prosthesis Design Catheterization Extracorporeal Circulation

Phenomena and Processes16

Blood Coagulation Prothrombin Time Partial Thromboplastin Time Whole Blood Coagulation Time Thrombin Time Hemostasis Time Factors Dose-Response Relationship, Drug Drug Interactions Fibrinolysis Platelet Count Bleeding Time Platelet Activation Platelet Aggregation Chi-Square Distribution Pregnancy

Disciplines and Occupations2

Pharmacogenetics Evidence-Based Medicine

Information Science2

Incidence Drug Therapy, Computer-Assisted

Health Care31

Treatment Outcome Risk Factors Retrospective Studies Prospective Studies Follow-Up Studies Point-of-Care Systems Risk Assessment Perioperative Care Drug Substitution Rodent Control Incidence Practice Guidelines as Topic Randomized Controlled Trials as Topic Nursing Services Cohort Studies Clinical Protocols Clinical Trials as Topic Withholding Treatment Ambulatory Care Facilities Outpatient Clinics, Hospital Ambulatory Care Drug Utilization Physician's Practice Patterns Patient Selection Hospital Bed Capacity, 500 and over Perioperative Period Age Factors Cost-Benefit Analysis Feasibility Studies Chi-Square Distribution Cost Allocation

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Anticoagulants Warfarin International Normalized Ratio Thromboembolism Blood Coagulation Heparin Hemorrhage Prothrombin Time Acenocoumarol Lupus Coagulation Inhibitor Partial Thromboplastin Time Phenprocoumon Venous Thrombosis Thrombosis Atrial Fibrillation Heparin, Low-Molecular-Weight beta-Alanine Vitamin K Protein C Whole Blood Coagulation Time Antithrombins Blood Coagulation Tests Pulmonary Embolism Factor Xa Heparin Antagonists Venous Thromboembolism 4-Hydroxycoumarins Phenindione Administration, Oral Blood Coagulation Factors Thrombophlebitis Rodenticides Drug Monitoring Thrombin Time Prothrombin Antiphospholipid Syndrome Protein S Thrombophilia Platelet Aggregation Inhibitors Blood Coagulation Disorders Fibrinolytic Agents Aspirin Enoxaparin Thrombomodulin Hirudins Stroke Treatment Outcome Thrombin Pipecolic Acids Antithrombin III Vitamin K Epoxide Reductases Heart Valve Prosthesis Embolism Vena Cava Filters Hematoma Antibodies, Antiphospholipid Fibrin Fibrinogen Degradation Products Coagulants Hemostasis Benzimidazoles Citric Acid Recurrence Thiophenes Risk Factors Dalteparin Time Factors Factor V Hemofiltration Cerebral Hemorrhage Retrospective Studies Heparinoids Intracranial Hemorrhages Protamines Prospective Studies Thromboplastin Follow-Up Studies Coumarins Antibodies, Anticardiolipin Factor X Pyridones Activated Protein C Resistance Intracranial Embolism and Thrombosis Postoperative Hemorrhage Antithrombin III Deficiency Hirudin Therapy Point-of-Care Systems Thrombolytic Therapy Citrates Electric Countershock Protein C Deficiency Risk Assessment Perioperative Care Dermatan Sulfate Thrombocytopenia Femoral Vein Echocardiography, Transesophageal Iliac Vein beta 2-Glycoprotein I Dicumarol Ancrod

No FAQ available that match "anticoagulation anticoagulants"